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ttp://dx.doi.org/10.1016/j.ajpath.2015.01.027Insulin-like growth factor-1 receptor (IGF-1R) can regulate vascular homeostasis and endothelial function.
We studied the role of IGF-1R in oxidative stresseinduced endothelial dysfunction. Unilateral ureteral
obstruction (UUO) was performed in wild-type (WT) mice and mice with endothelial cell (EC)especiﬁc IGF-
1R knockout (KO). After UUO in endothelial IGF-1R KOmice, endothelial barrier dysfunction was more severe
than in WT mice, as seen by increased inﬂammatory cell inﬁltration and vascular endothelial (VE)ecadherin
phosphorylation. UUO in endothelial IGF-1R KO mice increased interstitial ﬁbroblast accumulation and
enhanced extracellular protein deposition as compared with the WT mice. Endothelial barrier function
measured by transendothelial migration in response to hydrogen peroxide (H2O2) was impaired in ECs.
Silencing IGF-1R enhanced the inﬂuence of H2O2 in disrupting the VEeprotein tyrosine phosphatase/VE-
cadherin interaction. Overexpression of IGF-1R suppressed H2O2-induced endothelial barrier dysfunction.
Furthermore, by using the piggyBac transposon system, we expressed IGF-1R in VE cells in mice. The
expression of IGF-1R in ECs also suppressed the inﬂammatory cell inﬁltration and renal ﬁbrosis induced by
UUO. IGF-1R KO in the VE-cadherin lineage of bone marrow cells had no signiﬁcant effect on the UUO-
induced ﬁbrosis, as compared with control mice. Our results indicate that IGF-1R in the endothelium
maintains the endothelial barrier function by stabilization of the VEeprotein tyrosine phosphatase/VE-
cadherin complex. Decreased expression of IGF-1R impairs endothelial function and increases the ﬁbrosis
of kidney disease. (Am J Pathol 2015, 185: 1234e1250; http://dx.doi.org/10.1016/j.ajpath.2015.01.027)Supported by NIH grants RO1-DK095867 and R37-DK37175, VA grant
1I01 BX002190, American Heart Association grant 10SDG2780009, Sci-
ence and Technology Planning Project of Guangzhou, China, grant
2012J4300081, and a Dr. and Mrs. Harold Selzman grant.
Disclosures: None declared.Chronic kidney disease (CKD) is a major health care
problem that ultimately progresses to renal failure and the
need for dialysis and/or renal transplantation.1 Exaggerated
inﬂammation plays a critical role in acute and chronic renal
diseases, including obstructive kidney disease, glomerulo-
nephritis, and ischemia-reperfusioneinduced nephropathy.
Although systemic endothelial dysfunction is associated
with pathological changes in CKD, the role of the renal
endothelium in the initiation and the progression of renal
inﬂammation and ﬁbrosis remains largely elusive. In addi-
tion to its classic barrier function, the endothelium is a key
player in physiological processes, such as the regulation of
tissue inﬂammation and of thrombosis.2,3 Although endo-
thelial barrier integrity is essential to prevent inﬂammatorystigative Pathology.
.responses, few studies have explored the potential contri-
bution of impaired endothelial barrier function to CKD-
induced nephropathy, including ﬁbrosis.4
The insulin-like growth factor-1 receptor (IGF-1R) is a
member of the tyrosine kinase receptor superfamily that is
involved in the regulation of cellular proliferation, differ-
entiation, and survival.5 IGF-1R contributes to the mainte-
nance of paracellular barrier function in salivary gland cells
Loss of IGF-1R Impairs EC Functionvia the expression and distribution of tight junction pro-
teins.6 There are an increasing number of studies that show
that IGF-1R is a protective factor in endothelial cells (ECs).7
IGF-1 signaling inhibits hydrogen peroxide (H2O2)e
induced apoptosis in human umbilical vein ECs (HUVECs)
by reducing mitochondrial dysfunction. Speciﬁcally, the
protective mechanism of IGF-1 involves preserving the
mitochondrial membrane potential and reducing caspase-3
activity. Speciﬁc binding of IGF-1 to IGF-1R has been
demonstrated in kidney and retinal ECs,8e10 but whether
IGF-1R plays a protective role in CKD-induced patholog-
ical responses is unknown.
The vascular endothelium sits at the interface between the
blood stream and the vessel wall and is involved in the
regulation of metabolic hemostatic and immunological
processes. The regulation of EC contacts is of central
importance for the barrier function of the blood vessel wall
and for the control of leukocyte extravasation. Despite the
participation of several adhesion molecules and receptors in
the control of endothelial barrier, most of the currently
known mechanisms involve vascular endothelialecadherin
(VE-cadherin), an essential adhesion molecule for the sta-
bility of endothelial junctions. VE-cadherin is believed to be
of dominant importance for the stability of EC contacts and,
consequently, most mechanisms that affect the stability of
endothelial junctions target VE-cadherin. The factors his-
tamine, thrombin, tumor necrosis factor (TNF)-a, vascular
endothelial growth factor (VEGF)-A, and oxidative stress
were shown to increase tyrosine phosphorylation of various
components of the cadherin-catenin complex and increase
permeability of cultured EC monolayers.11
On the basis of these previous ﬁndings,7e10 we hypoth-
esized that IGF-1R has a critical role in the maintenance of
capillary architecture and function during CKD. Because
IGF-1 acts as an important survival factor for multiple cell
types, we undertook this study to investigate whether IGF-
1R favorably affects the barrier function of vascular ECs.
Materials and Methods
Animals
To generate mice with IGF-1R knocked out in the endothe-
lium, mice carrying a ﬂoxed IGF-1R allele12 were bred with
VE-cadherin-Cremice (Jackson Laboratory, BarHarbor,ME),
in which Cre is only expressed in ECs. After backcrossing, the
IGF-1Rf/f/VE-cadherin-Creþ [IGF-1R knockout (KO)] mice
were obtained. Although whole body KO of IGF-1R is fatal
and leads to embryonic death,13 we found that KO of IGF-1R
in ECs did not cause abnormality in gross appearance or male/
female ratio. Mice carrying this EC-speciﬁc mutation were of
normal size and weight and did not display any apparent renal
pathology in our experimental period. Red ﬂuorescent protein
(RFP)ﬂoxegreen ﬂuorescent protein (GFP) mice [B6.Cg-
Tg(CAG-DsRed-EGFP)5Gae/J, stock number 008705]14
were bred with VE-cadherin-Cre mice to evaluate theThe American Journal of Pathology - ajp.amjpathol.orgVE-cadherin-Cre efﬁciency. Mice were housed in a conven-
tional animal facility with a 12-hour light/dark cycle. Geno-
typing was performed using tail DNA. IGF-1R KO and
wild-type (WT) littermate control (VE-cadherin-Cree
negative) male mice, aged 3 to 4 months, were used in
experiments. All animal experiments were conducted in
accordance with accepted animal protocols (AN-6188 and
D1557) approved by the Institutional Animal Care and Use
Committee at the Baylor College of Medicine (Houston, TX).
Plasmid and Adenovirus Preparation
The adenovirus expressing IGF-1R was constructed by
inserting the IGF-1R cDNA into the pTracker-CMV vector,
and the adenovirus was prepared as reported previously.12 We
constructed the plasmid pT-VE-cad-IGF-1R, a transposon
containing the cDNA of IGF-1R under control of the
VE-cadherin promoter, by InFusion cloning (Clontech,
Mountain View, CA). pT-VE-cad-IGF-1R has the same
ampicillin-resistant backbone, piggyBac transposon inverted
repeats, and polyA signal components as the previously pub-
lished transposon plasmids pT-tight-Luc15 and pT-tight-
GSTA4.16 The VE-cadherin promoter was cloned by RT-PCR
frommouse genomic DNA.We generated the construct by gel
puriﬁcation of the linear plasmid backbone fragment con-
taining the piggyBac inverted repeats. We PCR ampliﬁed both
the VE-cadherin promoter and the IGF-1R cDNAs with the
following primers: VE-cad_F1 (50-AGATACTCGAGCTA-
GCCTAGTAGCAGAAACAAGGTC-30) and VE-cad_R1
(50-GGAGCCAGACTTCATGGTGGCGGCAGTCTGTCC-
AGGGCCGAG-30); or IGF-1R_F1 (50-ATGAAGTCTGGC-
TCCGGA-30) and IGF-1R_R1 (50-TCGACAAGCTTATC-
GATTCAGCAGGTCGAAGACTG-30). The primers gener-
ated regions of 15-bp homology, as required by the InFusion
enzyme. The primers also introduced a Kozak sequence and
two restriction enzyme sites: a NotI site between the VE-
cadherin promoter and the IGF-1R genes and a MluI site
between the IGF-1R sequence and the polyA signal. The three
fragments (VE-cadherin promoter, IGF-1R cDNA, and
backbone) were joined using InFusion, following the manu-
facturer’s instructions.
Reagents and Antibodies
Penicillin, streptomycin, Dulbecco’s modiﬁed Eagle’s me-
dium, and fetal bovine serum were obtained from Invitrogen
Life Technologies (Carlsbad, CA). The protein assay kit was
from Bio-Rad (Hercules, CA). The monoclonal a-smooth
muscle actin (SMA)eﬂuorescein isothiocyanate (FITC)
antibody, dextran-FITC, and Evans Blue Dye were from
Sigma-Aldrich (St. Louis, MO); VE-cadherin and CD31
antibodies were from BD Biosciences (San Jose, CA); IGF-
1Rb, von Willebrand factor, and platelet-derived growth
factor receptor (PDGFR)-b antibodies were from Santa Cruz
Biotechnology (Santa Cruz, CA); phosphorylated VE-
cadherin, F-actinephalloidineFITC, ﬂuorescent secondary1235
Liang et alantibodies, and Tyramide Signal Ampliﬁcation Kit were
from Invitrogen (Carlsbad, CA); protein tyrosine phospha-
tase (PTP) receptor b (VE-PTP) antibody was fromGene Tex
(Irvine, CA); CD42 and CD144 (VE-cadherin) antibodies
were from eBioscience (San Diego, CA); antibody against
PDGFR-a was from R&D (Minneapolis, MN); antibodies
against GFP (rabbit) were from Abcam (Cambridge, MA);
DAPI was from Southern Biotech (Birmingham, AL); and
macrophage marker F4/80 and rabbit antiea-SMA anti-
bodies were from Abcam (Cambridge, MA).
Renal Interstitial Fibrosis Model
Unilateral ureteral obstruction (UUO) or sham surgery was
performed on 3- to 4-month-old male mice, as described
previously.17,18 Male mice were anesthetized with an i.p. of
xylazine and ketamine cocktail (8.8 mg/kg xylazine and 130
mg/kg ketamine). Kidney tissue was harvested 3 or 7 days
after UUO or sham surgery. Because previous studies showed
no differences between these time points in shame
operated on mice,17 a single time point (day 3 or 7) was used
for sham controls in each experiment. Under anesthesia, the
left ureter was isolated and ligated for 3 or 7 days. For in vivo
gene delivery of IGF-1R in renal ECs, the plasmids pCMV-
piggyBac, pT-TetOn, and pT-VE-cad-IGF-1R were mixed
with endotoxin-free hydrodynamic injection solution QR
(Mirus, Madison, WI) and injected into the renal vein of one
kidney. Subsequently, UUO was generated. After 7 days,
animals were sacriﬁced and the kidneys were analyzed.
Renal IRI
We used an established mouse model of kidney ischemia/
reperfusion injury (IRI) induced by clamping of bilateral renal
pedicles. Male mice (age, 3 to 4 months; weight, 20 to 25 g)
were anesthetizedwith an i.p. injection of 2mL/kg combination
anesthetic. After abdominal incision, left and right renal pedi-
cles are bluntly dissected, and bilateral ischemiawas induced by
clamping of the renal pedicle for 30 minutes using a small
microvascular clamp (Roboz Surgical Instruments, Gaithers-
burg,MD), stopping blood ﬂow.During the procedure, animals
were kept on a heatingpadandhydratedwithwarmsaline.After
30 minutes of ischemia, the clamps were removed, allowing
reperfusion. The wounds were sutured, and the animals were
allowed to recover. Sham-treated mice had identical surgical
procedures except for clamping of the kidneys. Mice were
euthanized at 72 hours and 1 week after reperfusion, and kid-
neys were harvested for Western blot analysis.
BM Isolation and Transplantation
Bone marrow cells (BMCs) were obtained from tibias and
femurs of WT or IGF-1R KO mice. The transplant was
generated by injecting 5  106 BMCs into the lateral tail
vein of lethally irradiated (11 Gy) WT mouse recipients.19
Mice received kanamycin in their drinking water (2 mg/1236mL) for 14 days after transplantation. Mice were divided
into two groups with six animals in each group: WT mice
were transplanted with BMCs isolated from WT (control) or
from VE-cadherin-Creþ/IGF-1Rf/f mice. UUO surgeries
were performed 2 months later. After 7 days, the animals
were euthanized under anesthesia and the kidneys were
removed for analysis.
Assessment of Renal Function
Blood samples were collected for creatinine measurement after
sham surgery or day 7 after UUO. Serum creatinine was
measured using the Quanti Chrom Creatinine Assay Kit (Jaffe
method) as per themanufacturer’s instructions (Sigma-Aldrich).
Histology and Immunohistochemistry
For histological analysis, the kidneys were prepared by perfu-
sion of the mice through the left ventricle and slides of the
kidney were prepared as described.18 Histology scoring was
performed by examining periodic acideSchiffestained kidney
sections of ﬁve mice in each group by an experienced pathol-
ogist (M.L.) on coded slides. Immunohistochemical staining
was performed on kidney tissues using procedures established
in our laboratory.17,18 For double-immunoﬂuorescence stain-
ing, after primary antibodies, ﬂuorescent secondary antibodies
were incubated. DAPI was used to stain the nuclear DNA. The
Nikon Eclipse 80i ﬂuorescence microscope (Nikon, Melville,
NY) was used to capture the images, and the negative control
was either an isotype-matched IgG or phosphate-buffered sa-
line with Tween. The areas of positive signal were measured
using the NIS-Elements BR 3.0 program (Nikon). Picro-Sirius
Red staining was performed for assessment of collagen depo-
sition, as described.18 The amount of cortical ﬁbrillary collagen
was determined by observing areas stained with Picro-Sirius
Red with a Nikon Eclipse 80i ﬂuorescence microscope. To
determine GFP expression in RFPﬂox-GFP/VE-cadherin-Creþ
mice, the cryotissue sections were stained with anti-GFP pri-
mary antibody. After washing three times, the samples were
stainedwith anti-rabbit IgG antibody conjugated toAlexa Fluor
Cy5 dye (BD Biosciences). The images were obtained using a
Zeiss LSM-510 inverted deconvolution microscope with a
Zeiss Plan Apochromat 63 (numerical aperture, 1.4) objective
lens (Nikon).
Images (400 magniﬁcation) from each section were
analyzed in a blinded manner (J.L.) and quantiﬁed using
Image-Pro Plus software version 4.5 (Media Cybernetics,
Silver Spring, MD). The results were expressed as the
percentage of total tubulointerstitial area stained.
H2O2 Measurements
Kidneys were harvested and homogenized in 250 mL sucrose
buffer on ice, followed by protein quantitation (Bradford
method). H2O2 was measured as described previously.
20 The
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3þ-xylenol
orange complex. Brieﬂy, kidney lysate (100 mg/20 mL) was
added to 180 mL assay buffer, followed by measurement of
absorbance at 560 nm. Absorbance values were normalized
to the absorbance of wells containing assay buffer alone and
expressed as OD.
Measurement of mRNA Expression
Total kidney RNA was isolated by the RNeasy kit (Qiagen,
Valencia, CA). Real-time RT-PCR was performed with the
Opticon real-time RT-PCR machine (MJ Research, Waltham,
MA). The primers used were mouse ﬁbronectin (forward, 50-
TTCCAGAAGGTGATGAG-30; and reverse, 50-TCATGG-
CAATGCAGGACAGGAAGA-30), collagen I (forward,
50-TTCCAGAAGGTGATGAG-30; and reverse, 50-TCATG-
GCAATGCAGGACAGGAAGA-30), IGF-1R (forward, 50-
CGGCCAAGTACCCTTGGTTGAAAT-30; and reverse, 50-
AATGGAGCCACGGCAATCATCATC-30), a-SMA (for-
ward, 50-CTGACAGAGGCACCACTGAA-30; and reverse,
50-GAAATAGCCAAGCTCAG-30), and glyceraldehyde-3-
phosphate dehydrogenase (forward, 50-AGTGGGAGTTGC-
TGTTGAAATC-30; and reverse, 50-TGCTGAGTATGTC-
GTGGAGTCTA-30).
Western Blot Analysis
The cell extracts were prepared in radioimmunoprecipitation
assay buffer, protein concentration in the extracts was
determined by Bradford protein assay kit (Bio-Rad, Her-
cules, CA), and approximately 30 mg of protein was sepa-
rated by SDS-PAGE. After transferring to nitrocellulose
membranes, immunoblots were probed separately with
various primary antibodies after blocking with 5% skimmed
milk in Tris-buffered saline. Fluorescently labeled second-
ary antibodies were used for detection by the Odyssey
Infrared Imaging System (LI-COR, Inc., Lincoln, NE).
Transmission Electron Microscopy
Mice were sacriﬁced at 3 days after UUO or sham operation.
The kidneys were perfused with PBS and ﬁxed by immersion
in 0.1 mol/L cacodylate buffer containing 2.5% glutaralde-
hyde. Samples were dehydrated through ascending grades of
ethanol, embedded, divided into sections (90 nm thick), and
stained with lead citrate and 2% aqueous uranyl acetate. They
were dehydrated through ascending grades of ethanol. Sam-
ples were examined with the JEM-1200 transmission electron
microscope (JEOL, Peabody, MA) in the Baylor College of
Medicine core facility.
Qualitative Evaluation of Vascular Permeability by
Injection of Evans Blue Dye
Vascular permeability was determined by intravascular in-
jection of Evans Blue Dye (Sigma-Aldrich). Evans BlueThe American Journal of Pathology - ajp.amjpathol.orgDye (20 mg/g mouse body weight and 2 mg/mL in 0.9%
NaCl) was injected into the mouse jugular vein. After 30
minutes, dye remaining in the vessels was washed out by
perfusing the mouse with 0.9% NaCl via a needle inserted
into the left ventricle of the heart. The mouse was then
euthanized immediately, and the kidneys were removed.
Each kidney was cut into two pieces along the horizontal
plane, and both pieces were weighed. One piece was used
for Evans Blue Dye extraction with 100% formamide
(4 mL/g wet kidney weight) at room temperature for 24
hours. The other piece was dried for 24 hours at 55C and
weighed to obtain the ratio of dry/wet weight. The extracted
dye was measured by spectrophotometry (absorbance at 620
nm) using a 96-well plate reader. The results were calcu-
lated from a standard curve of Evans Blue Dye (0.05 to
50 mg/mL) and expressed as mg/g dry kidney weight.Cell Culture and Transfections
HUVECs were purchased from Lonza (Basel, Switzerland).
Cells were cultured in Clonetics MEGM Bullet Kit media
(Lonza) and starved of supplement growth factors for 24
hours before stimulation with reagents. All assays were per-
formed between passages 4 and 8. TNF-a (Sigma-Aldrich)
was used at a dose of 20 ng/mL, and recombinant VEGF (C-1;
Santa Cruz Biotechnology) was used at 10 ng/mL. For RNA
silencing of the IGF-1R in cells, predesigned Silencer Select
siRNAs for human IGF-1R and negative control (none tar-
geting siRNA) were purchased from Thermo Scientiﬁc
(Waltham, MA). Transfection was done with Lipofectamine
2000 (Life Technologies, Grand Island, NY), according to the
manufacturer’s instructions. Brieﬂy, cells were seeded at
1  106 cells per 6-well plate and incubated for 24 hours. A
mixture was prepared of 50 pmol siRNA with 5 mL of Lip-
ofectamine 2000 and added to the culture drop by drop. After
24 hours of transfection, medium was changed to normal
medium containing antibiotics. Cells were either treated after
24 hours at 90% to 95% conﬂuence or as otherwise stated.
RNA was extracted 24 hours after transfection for real-time
RT-PCR analyses, and cell lysates were prepared 48 hours
after transfection for Western blot analyses.In Vitro Permeability Assay
Conﬂuent HUVECs were seeded on 1% gelatin-coated
Transwell inserts (0.4-mm pore size; Becton Dickinson,
Franklin Lakes, NJ) in 12-well plates and cultured in the
upper chamber. At the start of the experiment, HUVECs
were transfected with siRNAeIGF-1R or nonrelated
scrambled siRNA, or infected with adenovirus (Ad)eIGF-
1R, and cultured for 24 to 72 hours. Afterward, 20 mg/mL
FITC-dextran (4-kDa relative molecular mass; Sigma-
Aldrich) was added to the upper chamber after HUVECs
were pretreated with 100 mmol/L H2O2 for 1 hour at 37C.
The medium (100 mL) was taken from the lower1237
Liang et alcompartment every 1 hour and measured using the Tecan
microplate reader (excitation, 480 nm; emission, 530 nm).
Renal Microvascular EC Isolation
The method used to isolate the renal microvascular ECs was
adapted from that described by Jackson et al.21 We used
antiePECAM-1 ferrous Dynabeads (Invitrogen, Carlsbad,
CA) to immunomagnetically separate the ECs from the
other cells present in the renal cortex.22
Transmigration of BMCs
The BMCs were isolated from male C57BL/6 mice, as
described.19 HUVECs were transfected with siRNAeIGF-
1R or nonrelated scrambled siRNA for 48 hours, or infected
with AdeIGF-1R. HUVECs were cultured in proprietary
medium (PromoCell) until conﬂuence in porous ﬁlter inserts
(5-mm pore size Transwell; Corning, Corning, NY) and
activated for 6 hours with 100 mmol/L H2O2. After 6 hours,
the medium was replaced and BMCs (2  106 in 100 mL)
were added. The BMCs were subsequently allowed to
transmigrate for 2 hours in a humidiﬁed CO2 incubator at
37C. The transmigrated BMCs were quantiﬁed by micro-
scopy (Nikon, Tokyo, Japan).
Statistical Analysis
All data are presented as the means  SEM. Comparison
between groups was made using one-way analysis of vari-
ance, followed by pairwise comparisons with P value
adjustment; P < 0.05 was considered to be statistically
signiﬁcant.
Results
Endothelial-Speciﬁc KO of IGF-1R Induces Interstitial
Fibroblast Accumulation after UUO
We found that the protein level of IGF-1R was dramatically
decreased in kidneys of UUO mice at days 3 and 7 as
compared to untreated control kidneys (Figure 1, A and B).
Similarly, in a renal IRI model, IGF-1R expression was
dramatically decreased at 3 days after IRI and recovered to
normal levels by day 7 (Figure 1C). Our results were
consistent with a previously reported decrease in mRNA
expression of IGF-1R in the rat IRI model.23 To investigate
whether the level of IGF-1R expression in ECs modulates
UUO-induced renal ﬁbrosis, mice with EC-speciﬁc KO of
IGF-1R (VE-Creþ/IGF-1Rf/f, IGF-1RKO)were generated by
crossing IGF-1Reﬂoxed mice with VE-cadherin-Cre trans-
genic mice (Figure 1D). The IGF-1R KOmice had decreased
levels of IGF-1R protein when compared with WT mice
(Figure 1E). Immunohistochemical analysis revealed a
marked decrease of IGF-1R expression in the ECs of the renal
arteriole from IGF-1R KO mice (Figure 1F). To further1238evaluate the efﬁciency of VE-cadherin-Cre, we used RFPﬂox-
GFP/VE-cadherin-Cre reporter mice to express GFP in VE-
cadherin-Creepositive cells.14 The GFP-positive cells were
found in the glomerular, peritubular capillaries and arterioles
(Figure 1G). These GFP-positive cells also expressed endo-
thelial marker CD31 (Figure 1G), and represent approxi-
mately 85.5%  2.79% of total CD31-positive cells
(Figure 1H). This result indicates that VE-cadherin-Cre ex-
presses functional Cre in ECs in kidneys.
To determine whether IGF-1R in vascular ECs contributes
to renal ﬁbrosis, we performed UUO in IGF-1R KO mice.
IGF-1Rf/f littermates were used as controls. The expressions
of a-SMA and PDGFR-a were monitored to represent myo-
ﬁbroblast accumulation. After UUO, the protein and mRNA
levels of PDGFR-a and a-SMAwere increased, an effect that
was further enhanced in the kidneys of IGF-1R KO mice
(Figure 1, I and J). Immunostaining results indicated that KO
of IGF-1R in ECs increased the number of interstitial ﬁbro-
blasts (a-SMAþ and PDGFR-aþ cells) in the obstructed
kidney versus that of WT mice (Figure 1, K and L).
Exaggeration of Tubulointerstitial Fibrosis in
IGF-1ReDeﬁcient Mice
After UUO, blood samples were harvested for serum
creatinine content measurements. The levels of serum
creatinine in IGF-1R KO mice were not statistically
signiﬁcantly different from WT mice after UUO
(Figure 2A), indicating that the contralateral (unobstructed)
kidney sufﬁced for normal excretion. Several renal patho-
logical phenotypes could be observed in both IGF-1R KO
and WT mice after UUO. These alterations include tubular
atrophy, inﬁltration of leukocytes, the expanded tubular
interstitial volume, and the overaccumulation of the extra-
cellular matrix (Figure 2, B and C). Mice with endothelial
KO of IGF-1R displayed signiﬁcantly severe tubular injury,
as determined histologically and by pathological scoring of
tubular injury. The degree of injury was similar for both
IGF-1R KO and WT mice 7 days after UUO, as indicated by
the dilation of tubular lumens in obstructed kidneys
(Figure 2B). However, interstitial collagen deposition on
Masson’s trichromeestained (Figure 2C) and Picro-Sirius
Red sections (Figure 2, D and E) was signiﬁcantly higher
in IGF-1R KO mice versus WT mice. No signiﬁcant his-
tological abnormality or ﬁbrosis was observed in the sham
control (Figure 2, CeE).
Oxidative stress can induce renal apoptosis and contribute
to the pathogenesis of the kidney after UUO. On days 1 and
7 after UUO, we measured the renal reactive oxygen species
(ROS) measurement in vivo by the Fox assay on a chem-
iluminescence analyzer. We found that signiﬁcantly
increased ROS occurred after 24 hours of UUO in the
kidney, but the increased ROS levels were not signiﬁcantly
different between WT and IGF-1R KO mice. However, on
day 7, the level of H2O2 in IGF-1R KO mice was signiﬁ-
cantly higher in the UUO group compared to WT miceajp.amjpathol.org - The American Journal of Pathology
Figure 1 Insulin-like growth factor-1 receptor (IGF-1R) knockout (KO) in endothelial cell (EC) increases unilateral ureteral obstruction (UUO)einduced myo-
ﬁbroblast accumulation. A: Determination of total IGF-1R levels in mouse kidneys. Protein was prepared from sham control (C) and obstructed kidneys of wild-type
(WT) mice. The level of IGF-1R was determined by Western blot analysis. B: Density analysis of IGF-1R protein levels in A. C: Representative Western blot analysis of
total IGF-1R levels in ischemia/reperfusion injury (IRI) kidneys. D: Strategy used to generate mice with EC-speciﬁc KO of IGF-1R. IGF-1Rﬂf mice were crossed with
vascular endothelialecadherin (VE-Cad)eCreþ mice to generate IGF-1Rf/f/VE-cadherin-Creþ mice (IGF-1R KO). E: Detection of IGF-1R expression by Western blot
analysis from kidneys of WT and IGF-1R KO mice. F: IGF-1R staining of renal vessels. Renal tissues were collected from WT mice and IGF-1R KO mice. IGF-1R was
detected by immunostaining (brown). G: VE-cadherin-Cre/IGF-1Rf/f mice were crossed to double-ﬂuorescent Cre reporter mice. Green ﬂuorescent protein (GFP)
represents the activity of Cre recombinase. Representative image of costaining of CD31 (red, pseudocolor) and GFP. H: Quantiﬁcation of CD31- and GFP-positive
areas. I and J: Myoﬁbroblast accumulation increases in IGF-1R KO mice after UUO. Myoﬁbroblast cell markers a-smooth muscle actin (SMA) and platelet-derived
growth factor receptor (PDGFR)-a were detected by Western blot analysis (I), real-time RT-PCR (J), and immunostaining (K and L). *P < 0.05. nZ 5 (B); nZ
3 (C); nZ 6 (IeL). Ctl, control; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; U1, UUO sample from animal 1; U2, UUO sample from animal 2.
Loss of IGF-1R Impairs EC Function(Figure 2F). Our data suggest that similar oxidative stress
was initiated in WT and IGF-1R KO mice after UUO.
Moreover, the expression levels of matrix protein
collagen I and ﬁbronectin were detected by Western blot
analysis. Consistently, the results showed that IGF-1R KO
mice had a signiﬁcantly higher expression of these proteins
in the obstructed kidney versus the expression in WT mice
after UUO (Figure 2G). The density analysis revealed a
signiﬁcant difference in protein expression between WT and
IGF-1R KO mice (Figure 2, H and I).
IGF-1R KO Mice Display Exaggerated Tubulointerstitial
Inﬂammation after UUO
Inﬂammation is a critical factor in the development of renal
ﬁbrosis. The obstructed kidneys in IGF-1R KO mice show
severe inﬁltration of inﬂammatory cells with interstitial area
extension, especially interstitial area surrounding the vessels,The American Journal of Pathology - ajp.amjpathol.orgby periodic acideSchiff staining (Figure 3A). Consistent with
the increase in inﬁltration of inﬂammatory cells, mRNA
expression of the IL-1b, inducible nitric oxide synthase,
transforming growth factor-b1, and monocyte chemoattractant
protein-1 genes was signiﬁcantly up-regulated in the kidneys
of IGF-1R KO mice compared with that of WT mice after
UUO (Figure 3B). To determine whether the preserved renal
architecture was associated with an increase in inﬂammation,
we performed immunohistochemistry analysis. Probing for the
pan-leukocyte marker CD45, we determined that the IGF-1R
KO in ECs resulted in a signiﬁcant increase in leukocyte
inﬁltration at 3 and 7 days after UUO as compared with WT
(Figure 3C). Image analysis of CD45 staining conﬁrmed a
signiﬁcant increase in leukocyte inﬁltration in the IGF-1R KO
mice (Figure 3D). The leukocyte populations presented within
injured kidneys consisted primarily of F4/80-positive macro-
phages, which were increased in IGF-1R KO mice at 3 and 7
days after UUO (Figure 3, E and F). Together, these data1239
Figure 2 Endothelial knockout (KO) of insulin-
like growth factor-1 receptor (IGF-1R) exacerbates
renal ﬁbrosis in unilateral ureteral obstruction
(UUO). A: The Src levels were determined in wild-
type (WT) and IGF-1R KO mice after UUO. B: Pe-
riodic acideSchiff staining demonstrates dilation
of the tubular lumen and thickness of basement
membrane of tubules in WT and IGF-1R KO mice. C:
Masson trichrome staining shows interstitial
collagen deposition (blue) in kidneys from mice
subjected to UUO. D: Enhanced collagen synthesis
and deposition are shown by Picro-Sirius Red
staining. E: The relative density analysis of Picro-
Sirius Redestained sections, such as those shown
in D. F: Hydrogen peroxide (H2O2) production in
kidney lysates at 1 and 7 days after UUO. G:
Extracellular matrix collagen (Col) and ﬁbronectin
(Fn) were detected by Western blot analysis. H and
I: The results from quantiﬁcation of these images
by computer-assisted image analysis, expressed as
percentage of the positive area. Data are given as
means  SEM (A, E, F, H, and I). n  6 mice (A, E,
F, H, and I). *P < 0.05. C, control; GAPDH,
glyceraldehyde-3-phosphate dehydrogenase; U1,
UUO sample from animal 1; U2, UUO sample from
animal 2.
Liang et alsuggest that the proinﬂammatory response after UUO was
exaggerated in IGF-1R KO mice as compared to WT mice.
IGF-1R KO in VE-Cadherin Lineage Hematopoietic Cells
Does Not Involve UUO-Induced Pathological Changes
Because of the expression proﬁle of the VE-cadherin pro-
moter, Cre activation in the VE-cadherin-Cre mice occurs not
only in the ECs, but also in the hematopoietic cells.24 To
evaluate the role of IGF-1R of hematopoietic cells in UUO-
induced inﬂammation and ﬁbrosis, UUO was performed in
WT mice that were transplanted with BMCs from WT mice
(WT/WT) or IGF-1Rf/f//VE-cadherin-Creþ mice (WT/IGF-
1R KO). No signiﬁcant differences in pathological change
were found in obstructed kidneys in the two groups. The
dilation of tubular lumens (Supplemental Figure S1A) and
interstitial collagen deposition (Supplemental Figure S1, B
and C) was not signiﬁcantly different in the obstructed kid-
neys (7 days after UUO) of WT/IGF-1R KO chimeric mice
versus WT/WT mice. Quantiﬁcation of CD45þ cells showed1240no signiﬁcant difference in obstructed kidneys from mice
with either WT or IGF-1Rf/f//VE-cadherin-Creþ BMCs
(Supplemental Figure S1, D and E). Consistently, the protein
expression levels of a-SMA and ﬁbronectin were increased to
a comparable level in both groups (Supplemental
Figure S1F). These results indicate that IGF-1R KO in the
ECs, but not in the hematopoietic cells, of a VE-cadherin
lineage plays an essential role in the progress of inﬂamma-
tion and ﬁbrosis in the obstructed kidneys.
IGF-1R Deﬁciency Is Associated with EC Barrier
Dysfunction after UUO
We performed transmission electron microscopy to examine
the structural alteration of renal capillary ECs in kidneys of
WT and IGF-1R KO mice after UUO (Figure 4A). ECs
showed more severe loss of the cellular junctions after
UUO, with many more cell processes and morphological
changes occurring in the IGF-1R KO mice than in the WT
mice. VE-cadherin is an important molecular component ofajp.amjpathol.org - The American Journal of Pathology
Figure 3 Loss of insulin-like growth factor-1 receptor (IGF-1R) in endothelial cells (ECs) aggravates the inﬂammation after unilateral ureteral obstruction
(UUO). A: Periodic acideSchiff staining shows increased inﬁltration of inﬂammatory cells in interstitial and perivascular areas in IGF-1R KO mice at day 7 after
UUO. B: Deletion of IGF-1R in ECs up-regulates the expression of chemokine genes in the obstructed kidney. Representative real-time PCR analysis and
quantitative data are shown. Relative mRNA levels (fold induction over sham controls) were reported after normalization with glyceraldehyde-3-phosphate
dehydrogenase (GAPDH). C: CD45 immunohistochemistry in kidney sections prepared at 3 and 7 days after UUO. D: Quantitative analysis shows a signiﬁ-
cant increase in the percentage of CD45þ cells per ﬁeld in vascular endothelial (VE)/IGF-1R/ mice. E and F: F4/80 expression was detected by immuno-
histochemistry, and the positive cells were counted. *P < 0.05, **P < 0.01 versus WT UUO. nZ 6 (AeF). Ctl, control; iNOS, inducible nitric oxide synthase;
MCP, monocyte chemoattractant protein; TGF, transforming growth factor; WT, wild type.
Loss of IGF-1R Impairs EC Functionthe capillary endothelial barrier. Increased tyrosine phos-
phorylation of VE-cadherin correlates with the disassembly
of EC junctions.25 To investigate the role of VE-cadherin in
the UUO model, VE-cadherin protein expression and its
phosphorylation were measured. We found a signiﬁcant
increase in the amount of tyrosine-phosphorylated
VE-cadherin (pVE-cadherin) in obstructed kidneys in the
IGF-1R KO mice versus WT mice at day 3 after UUO. TheThe American Journal of Pathology - ajp.amjpathol.orgtotal VE-cadherin showed no signiﬁcant changes between
the two groups (Figure 4B). The ratio of pVE-cadherin/
VE-cadherin was greater in the IGF-1R KO mice than that
in WT mice (Figure 4C).
Alteration in EC structure and increased phosphorylation
of VE-cadherin could lead to vascular leakage. Platelets are
the early response cells to EC damage. The platelet-speciﬁc
marker CD42 gave positive signals along the peritubular1241
Figure 4 Insulin-like growth factor-1 receptor (IGF-1R) knockout (KO) aggravates endothelial injury and impairs endothelial cell (EC) barrier
function in obstructed kidney. A: Transmission electron microscopy of peritubular capillaries at day 7 after unilateral ureteral obstruction (UUO)
kidney in wild-type (WT) and IGF-1R KO mice. At day 7 after UUO in IGF-1R KO mice, the endothelium of the peritubular capillary (En) is swollen
with marked cytoplasmic projections on the surface (arrows) in IGF-1R KO mice. B: Phosphorylation of vascular endothelialecadherin (VE-Cad) and
total VE-Cad was detected by Western blot analysis after UUO in WT and IGF-1R KO mice. C: The ratios of pVE-Cad/total VE-Cad. D: Platelet marker
CD42 was detected by immunostaining at day 3 after UUO in WT and IGF-1R KO mice. CD42 increases in peritubular capillaries in UUO kidneys from
IGF-1R KO mice. E: Permeability study performed by injection of Evans Blue Dye. The obstructed left kidney (3 days after UUO) of mice shows Evans
Blue Dye accumulation after saline washout, indicating that the obstructed kidneys retain more Evans Blue Dye than the contralateral kidneys.
F: ICAM-1 expression was detected by immunohistochemistry. Red arrows show the ICAM-1 in ECs. G: IGF-1R deﬁciency in human umbilical vein
endothelial cells leads to an increase in ICAM-1 and VCAM-1 mRNA expression on hydrogen peroxide (H2O2) treatment. Cells were transfected with
control (CTL) or small interfering IGF-1R. After 48 hours, cells were treated with 100 mmol/L H2O2 for 2 hours and harvested for RT-PCR. Data are
given as means  SEM (C). n Z 6 (C and E). *P < 0.05 pVE-Cad in IGF-1R KO mice versus WT (C), Evans Blue Dye in IGF-1R KO mice versus WT (E),
and mRNA levels in IGF-1R KO mice versus WT (G). C, control; U1, UUO sample from animal 1; U2, UUO sample from animal 2.
Liang et al
1242 ajp.amjpathol.org - The American Journal of Pathology
Loss of IGF-1R Impairs EC Functioncapillary endothelial lining that increased in the obstructed
kidney. Markedly increased staining of CD42 was noted in
IGF-1R KO mice compared with WT mice (Figure 4D). To
assess the changes in vascular permeability after UUO, the
deposition of penetrated Evans Blue Dye was measured
after perfusion. Evans Blue Dye levels were greater in the
IGF-1R KO mice than in WT mice (Figure 4E).
Because adhesion molecules may play an important role in
macrophage recruitment after the oxidative stress after UUO,
we detected intercellular adhesion molecule (ICAM)-1
protein expression. Immunohistochemistry staining with an
antieICAM-1 antibody showed only slight expression of
ICAM-1 in the glomerulus, peritubular capillaries, and
luminal area of tubule cells in sham control mice, but an
increase in ICAM-1 expression was found in the vascular
endothelium, tubular epithelium, and interstitial areas in the
obstructed kidney from both WT and IGF-1R KO mice.
Stronger ICAM-1 expression was apparent in the endothe-
lium of the renal arterioles of IGF-1R KO mice (Figure 4F).
Furthermore, we detected the vascular cell adhesion mole-
cule (VCAM)-1, ICAM-1, and E-selectin mRNA expres-
sion in HUVECs after treatment with H2O2. The in vitro
experiment showed that H2O2 treatment increased the
mRNA transcription of VCAM-1, ICAM-1, and E-selectin
in ECs and that the increase was greater for VCAM-1 and
ICAM-1 in the IGF-1R knockdown HUVECs (Figure 4G).
Taken together, our data suggest that IGF-1R in vascular
ECs may also be involved in regulating the expression of
endothelial adhesion molecules after stimulation due to
peroxidative stress.
Knockdown of IGF-1R in HUVECs Increases VE-Cadherin
Phosphorylation and Impairs Endothelial Barrier Under
Oxidative Stress
VE-cadherin phosphorylation is suppressed under normal
conditions, and increased VE-cadherin phosphorylation is
associated with increased endothelial barrier dysfunction.
Varied proinﬂammatory factors have been shown to cause
endothelial barrier dysfunction. Tyrosine phosphorylation of
VE-cadherin in HUVECs was stimulated by different fac-
tors, including VEGF, H2O2, and TNF-a (Figure 5A). From
these factors, we selected H2O2 for further study because
recent studies have documented an important role for
oxidative stress in several renal diseases.2 H2O2 increased
tyrosine phosphorylation of VE-cadherin in a time- and
dose-dependent manner. H2O2 (100 mmol/L) increased
pVE-cadherin as early as 15 minutes, with the peak occur-
ring at 30 minutes (Figure 5, B and C).
To investigate the effect of IGF-1R deﬁciency on H2O2-
induced phosphorylation of VE-cadherin, IGF-1R expression
was knocked down by siRNA (Figure 5D). On H2O2 treat-
ment, there was signiﬁcantly more VE-cadherin phosphory-
lation in the IGF-1R knockdown cells as compared to the
control (small interfering control)etreated HUVECs
(Figure 5E). TNF-a or VEGF, which are stressors forThe American Journal of Pathology - ajp.amjpathol.orgproducing endogenous H2O2,
26,27 markedly enhanced
VE-cadherin phosphorylation. Decreased expression of
IGF-1R resulted in signiﬁcantly higher VE-cadherin phos-
phorylation (Figure 5F). In mouse ECs isolated from WT and
IGF-1R KO mice, VE-cadherin was continuously distributed
along the cell membrane and well organized. H2O2 caused
early separation of cell-cell junctions (Figure 5G). IGF-1R
deﬁciency worsened the H2O2-induced alterations in IGF-1R
KO ECs (Figure 5G). Furthermore, we found that H2O2
induced actin polymerization in the membrane rufﬂes. On
stimulation with H2O2, the continuation of VE-cadherin on the
membrane was broken and showed a punctured pattern in
HUVECs. Knockdown of IGF-1R exacerbated the H2O2-
induced VE-cadherin disruption in HUVECs (Figure 5H).
Evidence for H2O2-induced EC permeability includes
enhanced dextran-FITC penetration, the loss of IGF-
1Reenhanced H2O2-induced FITC-dextran leakage, and
increased EC permeability when compared to the siRNA
control (Figure 5I). Furthermore, knockdown of IGF-1R
resulted in augmentation of transendothelial migration of
BMCs through the EC monolayers (Figure 5J). Collectively,
these data suggest that the phosphorylation of VE-cadherin
via IGF-1R signaling was involved in modulation of cyto-
skeletal remodeling that occurs during endothelial barrier
dysfunction.
IGF-1R Stabilizes the Association of VE-PTP with
VE-Cadherin
VE-PTP is an endothelial receptoretype phosphatase that
regulates tyrosine phosphorylation of VE-cadherin.28 To
address the mechanism of IGF-IR in regulating phosphory-
lation of VE-cadherin, the association of VE-cadherin with
VE-PTP or IGF-1R was determined. In normal conditions,
VE-cadherin was associated with VE-PTP in ECs and pre-
vented VE-cadherin phosphorylation. Treatment with H2O2
dissociated VE-PTP from VE-cadherin (Figure 6A).
Consistently, the pVE-cadherin was increased after H2O2
treatment (Figure 6A). In addition, we found that VE-
cadherin interacts with IGF-1R (Figure 6A). To test
whether IGF-1R is necessary for H2O2-induced VE-PTP/VE-
cadherin dissociation in ECs, IGF-1R expression was
knocked down by siRNA or overexpressed by AdeIGF-1R
infection. The H2O2-induced phosphorylation of VE-
cadherin was rescued by IGF-1R overexpression, whereas
IGF-1R deﬁciency exacerbated H2O2-induced VE-PTP/VE-
cadherin dissociation (Figure 6B). Increased IGF-1R
expression stabilized the VE-PTP/VE-cadherin complex
after H2O2 treatment (Figure 6C). Furthermore, over-
expression of IGF-1R also inhibited the disruptive effect of
H2O2 by restoring the linear distribution of the VE-cadherin
(Figure 6D). We evaluated the protective effects of IGF-1R
overexpression on endothelial barrier integrity. Treatment
with AdeIGF-1R inhibited H2O2-induced FITC-dextran
leakage and leukocyte transendothelial migration (Figure 6,
E and F). These results suggest a novel critical role of IGF-1R1243
Figure 5 Insulin-like growth factor-1 receptor (IGF-1R) deﬁciency increases the phosphorylation of vascular endothelialecadherin (VE-Cad) and
impairs endothelial barrier function. A: Human umbilical vein endothelial cells (HUVECs) were treated with 50 ng/mL vascular endothelial growth
factor (VEGF), 100 mm hydrogen peroxide (H2O2), and 10 ng/mL tumor necrosis factor (TNF)-a for 30 minutes. An immunoblot of phospho-Tyr731-
VE-Cad was performed. B and C: H2O2 stimulates VE-Cad phosphorylation in a manner that is dependent on both the time of exposure and dose of
H2O2. HUVECs were stimulated with H2O2 at a concentration of 100 mm at the indicated time period (B) or for 30 minutes at the indicated H2O2
concentration (C). D: IGF-1R expression in HUVECs was knocked down by IGF-1R siRNA. HUVECs were transfected with 10 nmol/L scrambled siRNA
or small interfering (si)eIGF-1R, and the IGF-1R protein level was detected after 48 hours. E: IGF-1R deﬁciency in HUVECs leads to an increase in
VE-Cad phosphorylation on H2O2 treatment. Cells were transfected with control or sieIGF-1R. After 48 hours of initial transfection, cells were
treated with 100 mmol/L H2O2 for 30 minutes. Then, cells were harvested for Western blot analysis. F: IGF-1R deﬁciency in HUVECs leads to an
increase in VE-Cad phosphorylation after TNF-a and VEGF treatment. Control or sieIGF-1R transfected cells were exposed to TNF-a and VEGF for 30
minutes. Then, cells were harvested for protein lysates and subjected to Western blot analysis. G: Mouse ECs isolated from wild-type (WT) and IGF-
1R KO mice were ﬁxed and stained with antibodies to VE-cadherin (red). White arrow shows the antieCD31-conjugated Dynabeads. H2O2 causes
intercellular gap formation (yellow arrows). H: HUVECs were seeded onto coverslips and transfected with scrambled siRNA or siRNA against IGF-1R.
After 48 hours, HUVECs were treated with vehicle or 100 mmol/L H2O2 for 30 minutes. Double staining with the F-actin antibody (green) and
antieVE-cadherin antibody (red) was performed. Images were visualized with an immunoﬂuorescence microscope. H2O2 stimulation enlarged gaps
between the HUVECs. Red arrows point to cell-cell junctions with defects in actin-VE-cadherin linkage between adjacent cells. Representative data
from three independent experiments are shown. I: IGF-1R deﬁciency enhances endothelial hyperpermeability. Cells were transfected and maintained
as above. An in vitro Transwell permeability assay was performed, and the amount of ﬂuorescein isothiocyanate (FITC)edextran diffused to the
lower chamber was measured. J: IGF-1R KO enhances H2O2-induced transendothelial migration. HUVECs were transfected with control or siRNA
against IGF-1R. After treating with H2O2 for 30 minutes, the medium was replaced and the bone marrow cells were added into the upper chamber.
Bone marrow cells in the lower chamber were counted. Data are given as means  SD (I and J). *P < 0.05. Ctl, control; GAPDH, glyceraldehyde-3-
phosphate dehydrogenase.
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Loss of IGF-1R Impairs EC Functionin preserving cell-cell adhesion and barrier function in
HUVECs.
Transposon-Mediated IGF-1R Expression Suppresses
UUO-Induced Inﬂammation and Fibrosis in IGF-1R KO
Mice
To explore the potential therapeutic role of IGF-1R in
obstructive renal injury, we constructed an IGF-1R expression
plasmid under control of the VE-cadherin promoter in a
piggyBac transposon vector to obtain the pT-VE-cadherin-
IGF-1R construct. It was then transferred into the kidney,
whichwas later subjected toUUO to induce interstitialﬁbrosis.
The gene transferwas accomplished using a transposon system
to integrate the IGF1R gene into the genomic DNA, so as to
achieve long-termgene expression.16,29 Initially,we conﬁrmed
that this systemmediates expression of IGF-IR in vascular ECs
by immunohistochemical staining (Figure 7A) and Western
blot analysis (Figure 7B). The positive immunostainingof IGF-
1R was restored in endothelium of renal vessels in mice with
IGF-1R overexpression (IGF-1R transposon [Tn]) that was
mediated by the transposon system (Figure 7A).Figure 6 Overexpression of insulin-like growth factor-1 receptor (IGF-1R) e
VEeprotein tyrosine phosphatase (PTP) and promotes endothelial barrier function
Human umbilical vein endothelial cells (HUVECs) were treated with H2O2 for 30 m
Immunoprecipitated proteins and the inputs were analyzed by Western blot analysis
and VE-PTP. HUVECs were transfected with small interfering (si)eIGF-1R or infected
minutes. Immunoprecipitation and Western blot analysis were performed. The IGF-
independent experiments. C: Overexpression of IGF-1R in HUVECs suppresses H2O
cadherin junction structure. HUVECs were infected with AdVector or AdeIGF-1R be
Overexpression of IGF-1R protects H2O2-induced barrier dysfunction. HUVECs were in
ﬂuorescein isothiocyanate (FITC)edextran (E) or transendothelial migration of bon
experiments. Data are given as means  SD (E and F). *P < 0.05. Ctl, control; GA
The American Journal of Pathology - ajp.amjpathol.orgTo test whether expression of IGF-1R in ECs inﬂuences
VE-cadherin phosphorylation, we examined pVE-cadherin
from the obstructed kidney in both IGF-1R KO and IGF-1R
Tn mice. We found that the extent of VE-cadherin phos-
phorylation was signiﬁcantly decreased in IGF-1R Tn mice
when compared to IGF-1R KO mice (Figure 7C). We then
determined the degree of endothelial leakage by Evans Blue
Dye detection. The deposited Evans Blue Dye levels were
signiﬁcantly lower in IGF-1R overexpression mice than in
IGF-1R KO mice (Figure 7D).
Notably, there was a signiﬁcant reduction in inﬂamma-
tory cell inﬁltration (leukocyte, CD45þ; macrophage, F4/
80þ) in the obstructed kidney in IGF-1R Tn mice versus
the IGF-1R KO mice after UUO (Figure 7E). Similarly, the
UUO-induced increase in chemokines was also signiﬁ-
cantly suppressed by IGF-1R overexpression (Figure 7F).
Periodic acideSchiff and Picro-Sirius Red staining and
quantitative assessment conﬁrmed that IGF-1R over-
expression in kidneys resulted in a signiﬁcant reduction in
ﬁbrosis at day 7 of UUO when compared to the IGF-1R
KO kidneys (Figure 7, GeK). Consistent with these
observations, reduced expression of ﬁbronectin, a-SMA,nhances interaction between vascular endothelialecadherin (VE-Cad) and
. A: Hydrogen peroxide (H2O2) dissociates VE-Cad from phosphatase VE-PTP.
inutes. Immunoprecipitation was performed with antieVE-Cad antibodies.
. B: Knockdown of IGF-1R enhances H2O2-induced dissociation of VE-cadherin
with adenovirus (Ad)eIGF-1R for 48 hours, followed by H2O2 treatment for 30
1R levels from the input were detected. The data are representative of three
2-induced VE-Cad phosphorylation. D: Overexpression of IGF-1R preserves
fore H2O2 treatment. VE-Cad (red) immunostaining was performed. E and F:
fected with control or AdeIGF-1R and treated with H2O2. The permeability of
e marrow cells (F) was determined. Data are representative of three repeated
PDH, glyceraldehyde-3-phosphate dehydrogenase.
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Liang et aland collagen I in IGF-1R overexpression mice was found
as compared with IGF-1R KO mice (Figure 7, H and I).
These data suggest that up-regulation of IGF-1R expres-
sion in WT mice serves to limit the increase in renal
vascular permeability and positively inﬂuences inﬂamma-
tion and ﬁbrosis after UUO.Figure 7 Transposon-mediated insulin-like growth factor-1 receptor (IGF-1R)
induced inﬂammatory and ﬁbrogenic responses in IGF-1R knockout mice. A and
plasmids were injected into the kidneys of IGF-1R knockout (KO) mice. After 3
Western blot analysis (B). C: Transposon-delivered IGF-1R expression inhibits vasc
transposon (Tn) mice after UUO. D: Overexpression of IGF-1R reverses UUO-induced
or IGF-1R Tn mice at day 3 after UUO. The deposited dye was measured by spectro
induced inﬂammatory response. E: After UUO was performed in both IGF-1R KO or I
kidneys. F: The expression of chemokines was detected by real-time RT-PCR. G: IGF
was performed 7 days after UUO. H and I: The protein levels of myoﬁbroblasts an
density is shown (I). J: Immunostaining of myoﬁbroblast and ﬁbrosis markers in b
Sirius Red staining in J. Data were means  SEM. nZ 6 (AeF). *P < 0.05. Ctl, co
derived growth factor receptor; SMA, smooth muscle actin; U1, UUO sample from
1246Discussion
The results of this study conﬁrm that EC damage and
endothelial barrier dysfunction are the initial factors in
obstructive kidney pathological changes. IGF-1R in ECs
shows a protective role in the maintenance of EC barrierexpression in vivo protects against unilateral ureteral obstruction (UUO)e
B: IGF-1R expression in renal endothelial cells (ECs). IGF-1R expression
days, the IGF-1R expression was determined by immunostaining (A) or by
ular endothelialecadherin (VE-Cad) phosphorylation in IGF-1R KO or IGF-1R
endothelial barrier dysfunction. Evans Blue Dye was injected into IGF-1R KO
photometry. E and F: Overexpression of IGF-1R in ECs suppresses the UUO-
GF-1R Tn mice, inﬂammatory cells (F4/80þ and CD45þ) were detected in the
-1R expression reduces UUO-induced ﬁbrosis. Periodic acideSchiff staining
d ﬁbronectin were detected by Western blot analysis (H), and the relative
oth the IGF-1R KO or IGF-1R Tn mice after UUO. K: Density analysis of Picro-
ntrol; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; PDGFR, platelet-
animal 1; U2, UUO sample from animal 2.
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Loss of IGF-1R Impairs EC Functionintegrity. Speciﬁc KO of IGF-1R in vascular ECs increases
permeability and inﬁltration of inﬂammatory cells, pro-
moting a signiﬁcant, progressive, renal interstitial ﬁbrosis in
the mouse UUO model of CKD. These changes were
associated with a signiﬁcant increase in VE-cadherin protein
phosphorylation. The in vitro experiments showed that loss
of IGF-1R increased the permeability of the endothelial
monolayer after H2O2 treatment. This augmented the disrup-
tion of the VE-PTP/VE-cadherin complex at adherens junc-
tions, leading to tyrosine phosphorylation of VE-cadherin.
Finally, the IGF-1R overexpression in the endothelium
resulted in the attenuation of interstitial inﬂammation and
ﬁbrosis. Taken together, the current data indicate that IGF-1R
in ECs plays a critical role in the maintenance of vascular
integrity via enhancing the stability of VE-cadherin at endo-
thelial junctions.
The endothelial monolayer lies at the interface between
blood and the extravascular space, playing a crucial role in
vascular homeostasis.30 Maintaining the functional integrity
of the endothelium is important in the prevention or delay of
vascular diseases. Endothelial dysfunction is a hallmark of
CKDandbegins early in the progression ofCKD.31 It has been
widely reported that patients with CKD display endothelial
dysfunction.31 In pathological conditions, injury to vascular
ECs results in increased permeability of the vascular barrier,
with increased extravasation of neutrophils and monocytes
across the vessel wall.32 We found that there was endothelial
damage and platelet aggregation in the interstitial capillary in
the obstructed kidneys (Figure 4). These indications of a leaky
EC barrier were further supported by increased Evans Blue
Dye staining in the UUO kidneys (Figure 4E).
There are several potential points that link EC barrier
dysfunction with renal ﬁbrosis. ECs are involved in modu-
lating local hemostasis and thrombolysis, producing vasoac-
tive compounds, and providing a nonpermeable barrier
preventing local activation and proliferation of local ﬁbro-
blasts or pericytes.33 First, the leakage of the endothelium can
promote platelet adhesion and aggregation, which is an im-
mediate response to EC damage. Platelets store proin-
ﬂammation molecules (sphingosine-1-phosphate) and growth
factors (PDGF and transforming growth factor-b1) that can
affect surrounding ﬁbroblast differentiation and proliferation.
Second, extravasation of the inﬂammatory cells through the
impaired endothelial layer causes them to accumulate in the
renal interstitial area. There, the inﬂammatory cells secrete
cytokines and chemokines, including monocyte chemo-
attractant protein-1,34 stromal cell-derived factor-1,35 and/or
others, that may stimulate myoﬁbroblast proliferation. In this
way, the inﬂammatory cells exert a paracrine effect on sur-
rounding cells.19 Finally, the endothelial damage could free
the coated pericytes, because the hyperplasia of pericytes also
leads to renal ﬁbrosis.36 We conclude that UUO-induced
endothelial barrier dysfunction is an initial factor that stimu-
lates inﬂammatory and ﬁbrogenic responses.
The molecules and factors in CKD that cause endothelial
changes are unclear, but it has been reported that treatmentThe American Journal of Pathology - ajp.amjpathol.orgof ECs with uremic serum increases the expression of
VCAM and tissue factor.37 Others have suggested that the
reduced EC function in CKD is possibly caused by
increased oxidative stress in the vascular wall.38,39 We
found that ROS (H2O2 and 4-hydroxynonenal) induced EC
barrier dysfunction (Figure 4). IGF-1R exerts multiple
physiological and pathological effects on the vasculature.
Accumulating evidence indicates that IGF-1R is a vascular
protective factor.40,41 It reduces oxidative stress and neu-
roinﬂammatory response.42 Increased IGF-1R improved
endothelial progenitor function and promoted endothelial
regeneration,43,44 whereas IGF-1R KO increased diabetes-
induced cardiac ﬁbrosis.45,46 It has been reported that
CKD impairs the IGF-1/IGF-1R signaling pathway, leading
to dysfunction of muscle regeneration.47 In conclusion, we
found that UUO decreased the expression of IGF-1R in
kidney (Figure 1), suggesting that endothelial IGF-1R could
play a role in renal ﬁbrosis.
To test this hypothesis, IGF-1R KO and WT mice were
subjected to UUO, and their outcomes were compared. The
kidneys of IGF-1R KO mice showed a greater increase in
vascular permeability, inﬂammatory cell inﬁltration, greater
accumulation of myoﬁbroblasts, and more deposition of
extracellular matrix (Figures 1 and 2). Consequently, loss of
IGF-1R in ECs mediated the barrier dysfunction in UUO,
which directly promotes ﬁbrosis via the accumulation of
inﬂammatory cells, especially macrophages (Figure 3).
UUO-induced accumulation of ﬁbroblasts and tubulointer-
stitial ﬁbrosis were signiﬁcantly exacerbated in IGF-1R KO
mice (Figures 1 and 2). In addition, these responses were
blunted in IGF-1R Tn mice (Figure 7). These ﬁndings
indicate that vascular endotheliumespeciﬁc IGF-1R plays a
pathological role in the progression of renal inﬂammation
via barrier dysfunction. Inﬁltration of platelets and inﬂam-
matory cells introduced cytokines that are critical mediators
of renal ﬁbrosis, such as IL-1b, inducible nitric oxide syn-
thase, and chemokine ligand-2/monocyte chemoattractant
protein-1.
VE-cadherin-Cre transgenic mice have been widely used
to deliver gene overexpression48 or knockout49 in ECs. By
using reporter transgenic mice, we found that most of the
CD31-positive ECs in the kidney (approximately
85.5%  2.79%) were labeled by GFP that was turned on by
VE-cadherin-Cre (Figure 1). With the same reporter mice, a
recent report showed that VE-cadherin-Cre was active in
only 50% of the kidney.50 This discrepancy could be due to
the different methods or antibodies used in the analysis.
The Cre recombinase expressed in the VE-cadherin-Cre
transgenic mice was predominantly active in ECs and, in
addition, in hematopoietic cells.24 Therefore, the IGF-1R
gene was knocked out in all VE-cadherineexpressing
cells (ECs) and their lineages (including some hematopoi-
etic cells). The deteriorative effects on renal ﬁbrosis in IGF-
1Rf/f/VE-cadherin-Creþ mice could be due to dysfunction in
the hematopoietic cells of VE-cadherin lineage. However,
transplant of BMCs from IGF-1Rf/f/VE-cadherin-Creþ mice1247
Liang et alinto WT mice had no observed effects on UUO-induced
ﬁbrosis. Therefore, our results indicate that loss of IGF-1R
in ECs was the major contributor to the accelerated UUO-
induced inﬂammatory and ﬁbrogenic response.
More important, because VE-cadherin is involved in
pericellular vascular permeability,51,52 we hypothesized
that its function may be modulated by IGF-1R. VE-
cadherin phosphorylation was measured at the critical
tyrosine residue Y-731, a mechanism causing disassembly
of this protein from the endothelial junction. Our data
indicate that after UUO, decreased IGF-1R in ECs
increased VE-cadherin phosphorylation, whereas the
overexpression of IGF-1R in the endothelium partially
restored its barrier function through decreased phosphor-
ylation of VE-cadherin (Figure 7). It has previously been
reported that IGF-1 prevented EC apoptosis by ROS,
whereas speciﬁc knockout of IGF-1R caused vascular
hyperpermeability and increased H2O2-induced tissue
injury.53 In cultured ECs, we also observed an increased
phosphorylation of VE-cadherin after treatment with
H2O2, whereas overexpression of AdeIGF-1R suppressed
this response (Figure 6C). These results demonstrate that
stabilization of endothelial junctions is a mechanism by
which IGF-1R reduces vascular hyperpermeability
through reduction of the VE-cadherin phosphorylation.
VE-PTP, a VE-cadherin phosphatase in ECs, determines
the phosphorylation status of VE-cadherin through direct
interaction. Consistently, decreased IGF-1R levels exac-
erbated the H2O2-induced dissociation of the VE-PTP/
VE-cadherin complex in ECs, whereas increased IGF-1R
expression restored the VE-PTP/VE-cadherin interaction
to control levels (Figure 6). Another key ﬁnding from our
study is the association of the IGF-1R with VE-cadherin
in HUVECs. This ﬁnding is supported by the co-
immunoprecipitation of the IGF-1R with VE-cadherin
from HUVEC whole cell lysates (Figure 6). Consistent
with our observations, studies have shown that in human
colonic mucosa, IGF-1R has been found complexed with
E-cadherin.54 The presence of IGF-1R complexed with
E-cadherin at points of cell-cell contact in corneal
epithelial cells has also been identiﬁed.54 A decrease in
IGF-1R expression led to a decreased amount of the
E-cadherinecatenin complex, causing a defect in the
epithelial barrier. These studies suggest that IGF-1R plays
a role in the stabilization of E-cadherinecatenin complex
in breast cancer cells.55 Our results strongly support the
interplay between the IGF-1R and VE-PTP/VE-cadherin
complex in maintenance of the cell-cell contact of
HUVECs in the absence of exogenous IGF-1. Further
studies are needed to investigate the regulatory pathways.
In summary, our study conﬁrms the critical role of IGF-
1R in regulation of the stability of the VE-PTP/VE-cadherin
complex, thereby affecting the phosphorylation state of
VE-cadherin. Through this mechanism, we found that
decreased IGF-1R expression impaired endothelial barrier
function at the interendothelial junctions after UUO.1248Acknowledgments
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